Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · IEX Real-Time Price · USD
2.200
-0.130 (-5.58%)
At close: Apr 18, 2024, 4:00 PM
2.260
+0.060 (2.73%)
After-hours: Apr 18, 2024, 6:12 PM EDT
Oramed Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ORMP stock has a target of 2.00, which predicts a decrease of -9.09% from the current stock price of 2.20.
Analyst Consensus: Hold
* Price targets were last updated on May 17, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for ORMP is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | -9.09% | May 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 17, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 12, 2023 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains $35 → $30 | Strong Buy | Maintains | $35 → $30 | +1,263.64% | May 16, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $20 | Buy | Initiates | $20 | +809.09% | Feb 18, 2022 |
Financial Forecast
Revenue This Year
1.33M
from 1.34M
Decreased by -1.04%
Revenue Next Year
n/a
from 1.33M
EPS This Year
-0.27
from 0.14
EPS Next Year
-1.10
from -0.27
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 2.1M | n/a |
| Avg | 1.3M | n/a |
| Low | 588,000 | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 56.7% | - |
| Avg | -1.0% | - |
| Low | -56.1% | - |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -0.12 | -1.13 |
| Avg | -0.27 | -1.10 |
| Low | -0.40 | -1.06 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.